In accordance with previous studies, the Systemic IL-10 treatment attenuated TNFα and IL-1β production at 24 h post-SCI, but failed to reach significance at 7 days post-SCI [ 14 , 46 , 47 ].
← all excerpts
Sustained interleukin-10 delivery reduces inflammation and improves motor function after spinal cord injury.
1
—
—